Immunocore Holdings Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Immunocore Holdings stock has a consensus rating of "Buy" and an average price target of $63.49. The average 1-year stock price forecast is 119.23% higher than the current stock price, while the lowest is $34 (+17.40%) and the highest is $100 (+245.30%).

Price Target: $63.49 (+119.23%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$34	$63.49	$62	$100
Change	+17.40%	+119.23%	+114.09%	+245.30%

Analyst Ratings

The average analyst rating for Immunocore Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	12	11	10	10	10	10
Buy	1	1	1	1	1	1
Hold	3	3	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	15	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Reiterates $100	Buy	Reiterates	$100	+245.30%	Jun 4, 2026
Gil Blum Needham	Needham	Buy Maintains $75	Buy	Maintains	$75	+158.98%	Jun 1, 2026
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Hold Maintains $38 → $34	Hold	Maintains	$38 → $34	+17.40%	May 8, 2026
Rajan Sharma Goldman Sachs	Goldman Sachs	Buy Maintains $72 → $73	Buy	Maintains	$72 → $73	+152.07%	May 7, 2026
Unknown Analyst Guggenheim No rating	Guggenheim	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

447.68M

from 400.02M

11.91%

from 400.02M

Revenue Next Year

485.90M

from 447.68M

8.54%

from 447.68M

EPS This Year

0.11

from -0.71

EPS Next Year

-0.67

from 0.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	36.48M	174.36M	249.43M	310.20M	400.02M	447.68M
Revenue Growth	-11.26%	377.91%	43.05%	24.37%	28.95%	11.91%
Gross Profit	-63.76M	167.96M	84.85M	85.32M	120.06M	443.45M
Gross Margin	-174.77%	96.33%	34.02%	27.50%	30.01%	99.06%
Operating Income	-174.66M	-51.70M	-60.55M	-52.41M	-25.63M	-9.65M
Net Income	-180.03M	-52.54M	-55.29M	-51.09M	-35.51M	2.53M
EPS	-	-	-	-	-0.71	0.11
Forward PE	-	-	-	-	-	258.69
Free Cash Flow	-50.31M	-19.73M	14.06M	38.39M	23.96M	-21.52M
No. Analysts	-	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	464.5M
Avg	447.7M
Low	433.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	16.1%
Avg	11.9%
Low	8.4%

EPS Forecast

EPS	2026	2027	2028
High	1.17
Avg	0.11
Low	-0.36

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-